| ■ 영문 제목 : Global Human Combination Vaccines Market 2023-2027
|
 | ■ 상품코드 : IRTNTR44620-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2022년 12월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (24시간 이내)
■ 조사대상 지역 : 북미, 유럽, 아시아, 기타 지역
■ 산업 분야 : 의약품
|
■ 판매가격 / 옵션
(부가세 10% 별도)
| Single User (1명 열람용) | USD2,500 ⇒환산￦3,500,000 | 견적의뢰/주문/질문 |
| Enterprise License (동일기업내 공유가능) | USD4,000 ⇒환산￦5,600,000 | 견적의뢰/주문/질문 |
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
|
테크나비오 조사회사는 세계의 인간용 혼합 백신 시장 규모가 2022년부터 2027년까지 연평균 8.13% 성장하여, 6,046.98백만 달러에 달할 것으로 예측하고 있습니다. 본 조사 보고서는 세계의 인간용 혼합 백신 시장을 조사 대상으로 하여, 개요, 시장 현황, 시장 규모 예측, 과거 시장 규모, 파이브 포스 분석, 종류별 (불활화 백신, 약독생 백신) 분석, 채널별 (병원, 소매, 온라인) 분석, 고객 현황, 지역별 현황 (북미, 유럽, 아시아, 기타 지역, 미국, 영국, 캐나다, 일본, 독일) 분석, 추진 요인/과제/동향, 기업 현황, 기업 분석 등의 항목을 게재하고 있습니다. 덧붙여 본 조사 자료는 Abbott Laboratories, Arabio, Bharat Biotech Ltd., Biological E. Ltd., Cadila Healthcare Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Grifols SA, LG Corp., Meiji Holdings Co. Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Panacea Biotec Ltd., Pfizer Inc., PT Bio Farma, Sanofi SA, Serum Institute of India Pvt. Ltd. Ltd., Walvax Biotechnology Co. Ltd.와 같은 기업 정보를 포함하고 있습니다.
・개요
・시장 현황
・시장 규모 예측
・과거 시장 규모
・파이브 포스 분석
・세계의 인간용 혼합 백신 시장 규모 : 종류별
- 불활화 백신의 시장 규모
- 약독생 백신의 시장 규모
・세계의 인간용 혼합 백신 시장 규모 : 채널별
- 병원 채널의 시장 규모
- 소매 채널의 시장 규모
- 온라인 채널의 시장 규모
・고객 현황
・세계의 인간용 혼합 백신 시장 규모 : 지역별
- 북미의 인간용 혼합 백신 시장 규모
- 유럽의 인간용 혼합 백신 시장 규모
- 아시아의 인간용 혼합 백신 시장 규모
- 기타 지역의 인간용 혼합 백신 시장 규모
- 미국의 인간용 혼합 백신 시장 규모
- 영국의 인간용 혼합 백신 시장 규모
- 캐나다의 인간용 혼합 백신 시장 규모
- 일본의 인간용 혼합백신 시장 규모
- 독일의 인간용 혼합 백신 시장 규모
・추진 요인/과제/동향
・기업 현황
・기업 분석
테크나비오사는 이익, 가격, 경쟁, 프로모션과 같은 주요 매개 변수를 분석하여, 다수의 소스로부터 데이터를 조사, 통합 및 합산하여 시장에 대한 상세하고 종합적인 결과를 제공합니다. 또한, 주요 산업의 영향 요인을 분석하여 시장의 다양한 관점을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 덧붙여 테크나비오사의 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해, 정성적 및 정량적 조사를 사용하여, 명확한 경쟁 현황과 상세한 벤더 선택 방법 및 분석을 제공합니다.
|
■ 보고서 개요Technavio Announces the Publication of its Research Report – Global Human Combination Vaccines Market 2023-2027Technavio recognizes the following companies as the key players in the global human combination vaccines market: Abbott Laboratories, Arabio, Bharat Biotech Ltd., Biological E. Ltd., Cadila Healthcare Ltd., CSL Ltd., Daiichi Sankyo Co. Ltd., GlaxoSmithKline Plc, Grifols SA, LG Corp., Meiji Holdings Co. Ltd., Merck and Co. Inc., Mitsubishi Chemical Holdings Corp., Panacea Biotec Ltd., Pfizer Inc., PT Bio Farma, Sanofi SA, Serum Institute of India Pvt. Ltd., Takeda Pharmaceutical Co. Ltd., and Walvax Biotechnology Co. Ltd.
Commenting on the report, an analyst from Technavio said: “The latest trend gaining momentum in the market is the threat from bioterrorism.”
According to the report, one of the major drivers for this market is increasing antiviral drug resistance.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. For further information on this report, please visit- www.technavio.com/report/human-combination-vaccines-market-industry-analysis
Technavio, the market research platform of Infiniti Research Ltd., publishes periodic market research reports on niche and emerging technologies. For more information on our market research, please visit- www.technavio.com/industries/pharmaceuticals
Follow us on Twitter @Technavio
■ 보고서 목차• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global human combination vaccines market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global human combination vaccines market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.3 Channel Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Channel Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Inactivated vaccine – Market size and forecast 2022-2027
o Exhibit 34: Chart on Inactivated vaccine – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Inactivated vaccine – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Inactivated vaccine – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Inactivated vaccine – Year-over-year growth 2022-2027 (%)
o 6.4 Live attenuated vaccine – Market size and forecast 2022-2027
o Exhibit 38: Chart on Live attenuated vaccine – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Live attenuated vaccine – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Live attenuated vaccine – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Live attenuated vaccine – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
• 7 Market Segmentation by Channel
o 7.1 Market segments
o Exhibit 43: Chart on Channel – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Channel – Market share 2022-2027 (%)
o 7.2 Comparison by Channel
o Exhibit 45: Chart on Comparison by Channel
o Exhibit 46: Data Table on Comparison by Channel
o 7.3 Hospitals – Market size and forecast 2022-2027
o Exhibit 47: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
o 7.4 Retailers – Market size and forecast 2022-2027
o Exhibit 51: Chart on Retailers – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Retailers – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Retailers – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Retailers – Year-over-year growth 2022-2027 (%)
o 7.5 Online – Market size and forecast 2022-2027
o Exhibit 55: Chart on Online – Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Online – Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Online – Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Online – Year-over-year growth 2022-2027 (%)
o 7.6 Market opportunity by Channel
o Exhibit 59: Market opportunity by Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 63: Chart on Geographic comparison
o Exhibit 64: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 65: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 81: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 85: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 Canada – Market size and forecast 2022-2027
o Exhibit 89: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.10 Japan – Market size and forecast 2022-2027
o Exhibit 93: Chart on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.11 Germany – Market size and forecast 2022-2027
o Exhibit 97: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 101: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 102: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 104: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 105: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 106: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 107: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 108: Abbott Laboratories – Overview
o Exhibit 109: Abbott Laboratories – Business segments
o Exhibit 110: Abbott Laboratories – Key news
o Exhibit 111: Abbott Laboratories – Key offerings
o Exhibit 112: Abbott Laboratories – Segment focus
o 12.4 Bharat Biotech Ltd.
o Exhibit 113: Bharat Biotech Ltd. – Overview
o Exhibit 114: Bharat Biotech Ltd. – Product / Service
o Exhibit 115: Bharat Biotech Ltd. – Key news
o Exhibit 116: Bharat Biotech Ltd. – Key offerings
o 12.5 Biological E. Ltd.
o Exhibit 117: Biological E. Ltd. – Overview
o Exhibit 118: Biological E. Ltd. – Product / Service
o Exhibit 119: Biological E. Ltd. – Key offerings
o 12.6 Cadila Healthcare Ltd.
o Exhibit 120: Cadila Healthcare Ltd. – Overview
o Exhibit 121: Cadila Healthcare Ltd. – Business segments
o Exhibit 122: Cadila Healthcare Ltd. – Key offerings
o Exhibit 123: Cadila Healthcare Ltd. – Segment focus
o 12.7 CSL Ltd.
o Exhibit 124: CSL Ltd. – Overview
o Exhibit 125: CSL Ltd. – Business segments
o Exhibit 126: CSL Ltd. – Key news
o Exhibit 127: CSL Ltd. – Key offerings
o Exhibit 128: CSL Ltd. – Segment focus
o 12.8 Daiichi Sankyo Co. Ltd.
o Exhibit 129: Daiichi Sankyo Co. Ltd. – Overview
o Exhibit 130: Daiichi Sankyo Co. Ltd. – Business segments
o Exhibit 131: Daiichi Sankyo Co. Ltd. – Key news
o Exhibit 132: Daiichi Sankyo Co. Ltd. – Key offerings
o Exhibit 133: Daiichi Sankyo Co. Ltd. – Segment focus
o 12.9 GlaxoSmithKline Plc
o Exhibit 134: GlaxoSmithKline Plc – Overview
o Exhibit 135: GlaxoSmithKline Plc – Business segments
o Exhibit 136: GlaxoSmithKline Plc – Key offerings
o Exhibit 137: GlaxoSmithKline Plc – Segment focus
o 12.10 Grifols SA
o Exhibit 138: Grifols SA – Overview
o Exhibit 139: Grifols SA – Business segments
o Exhibit 140: Grifols SA – Key offerings
o Exhibit 141: Grifols SA – Segment focus
o 12.11 LG Corp.
o Exhibit 142: LG Corp. – Overview
o Exhibit 143: LG Corp. – Business segments
o Exhibit 144: LG Corp. – Key offerings
o Exhibit 145: LG Corp. – Segment focus
o 12.12 Meiji Holdings Co. Ltd.
o Exhibit 146: Meiji Holdings Co. Ltd. – Overview
o Exhibit 147: Meiji Holdings Co. Ltd. – Business segments
o Exhibit 148: Meiji Holdings Co. Ltd. – Key news
o Exhibit 149: Meiji Holdings Co. Ltd. – Key offerings
o Exhibit 150: Meiji Holdings Co. Ltd. – Segment focus
o 12.13 Merck and Co. Inc.
o Exhibit 151: Merck and Co. Inc. – Overview
o Exhibit 152: Merck and Co. Inc. – Business segments
o Exhibit 153: Merck and Co. Inc. – Key news
o Exhibit 154: Merck and Co. Inc. – Key offerings
o Exhibit 155: Merck and Co. Inc. – Segment focus
o 12.14 Mitsubishi Chemical Holdings Corp.
o Exhibit 156: Mitsubishi Chemical Holdings Corp. – Overview
o Exhibit 157: Mitsubishi Chemical Holdings Corp. – Business segments
o Exhibit 158: Mitsubishi Chemical Holdings Corp. – Key offerings
o Exhibit 159: Mitsubishi Chemical Holdings Corp. – Segment focus
o 12.15 Pfizer Inc.
o Exhibit 160: Pfizer Inc. – Overview
o Exhibit 161: Pfizer Inc. – Product / Service
o Exhibit 162: Pfizer Inc. – Key news
o Exhibit 163: Pfizer Inc. – Key offerings
o 12.16 Sanofi SA
o Exhibit 164: Sanofi SA – Overview
o Exhibit 165: Sanofi SA – Business segments
o Exhibit 166: Sanofi SA – Key news
o Exhibit 167: Sanofi SA – Key offerings
o Exhibit 168: Sanofi SA – Segment focus
o 12.17 Serum Institute of India Pvt. Ltd.
o Exhibit 169: Serum Institute of India Pvt. Ltd. – Overview
o Exhibit 170: Serum Institute of India Pvt. Ltd. – Product / Service
o Exhibit 171: Serum Institute of India Pvt. Ltd. – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 172: Inclusions checklist
o Exhibit 173: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 174: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 175: Research methodology
o Exhibit 176: Validation techniques employed for market sizing
o Exhibit 177: Information sources
o 13.5 List of abbreviations
o Exhibit 178: List of abbreviations
Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global human combination vaccines market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Channel Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Inactivated vaccine – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Inactivated vaccine – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Inactivated vaccine – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Inactivated vaccine – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Live attenuated vaccine – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Live attenuated vaccine – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Live attenuated vaccine – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Live attenuated vaccine – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Chart on Channel – Market share 2022-2027 (%)
Exhibits44: Data Table on Channel – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Channel
Exhibits46: Data Table on Comparison by Channel
Exhibits47: Chart on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Hospitals – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Hospitals – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Retailers – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Retailers – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Retailers – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Retailers – Year-over-year growth 2022-2027 (%)
Exhibits55: Chart on Online – Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Online – Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Online – Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Online – Year-over-year growth 2022-2027 (%)
Exhibits59: Market opportunity by Channel ($ million)
Exhibits60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits63: Chart on Geographic comparison
Exhibits64: Data Table on Geographic comparison
Exhibits65: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits101: Market opportunity By Geographical Landscape ($ million)
Exhibits102: Impact of drivers and challenges in 2022 and 2027
Exhibits103: Overview on Criticality of inputs and Factors of differentiation
Exhibits104: Overview on factors of disruption
Exhibits105: Impact of key risks on business
Exhibits106: Vendors covered
Exhibits107: Matrix on vendor position and classification
Exhibits108: Abbott Laboratories – Overview
Exhibits109: Abbott Laboratories – Business segments
Exhibits110: Abbott Laboratories – Key news
Exhibits111: Abbott Laboratories – Key offerings
Exhibits112: Abbott Laboratories – Segment focus
Exhibits113: Bharat Biotech Ltd. – Overview
Exhibits114: Bharat Biotech Ltd. – Product / Service
Exhibits115: Bharat Biotech Ltd. – Key news
Exhibits116: Bharat Biotech Ltd. – Key offerings
Exhibits117: Biological E. Ltd. – Overview
Exhibits118: Biological E. Ltd. – Product / Service
Exhibits119: Biological E. Ltd. – Key offerings
Exhibits120: Cadila Healthcare Ltd. – Overview
Exhibits121: Cadila Healthcare Ltd. – Business segments
Exhibits122: Cadila Healthcare Ltd. – Key offerings
Exhibits123: Cadila Healthcare Ltd. – Segment focus
Exhibits124: CSL Ltd. – Overview
Exhibits125: CSL Ltd. – Business segments
Exhibits126: CSL Ltd. – Key news
Exhibits127: CSL Ltd. – Key offerings
Exhibits128: CSL Ltd. – Segment focus
Exhibits129: Daiichi Sankyo Co. Ltd. – Overview
Exhibits130: Daiichi Sankyo Co. Ltd. – Business segments
Exhibits131: Daiichi Sankyo Co. Ltd. – Key news
Exhibits132: Daiichi Sankyo Co. Ltd. – Key offerings
Exhibits133: Daiichi Sankyo Co. Ltd. – Segment focus
Exhibits134: GlaxoSmithKline Plc – Overview
Exhibits135: GlaxoSmithKline Plc – Business segments
Exhibits136: GlaxoSmithKline Plc – Key offerings
Exhibits137: GlaxoSmithKline Plc – Segment focus
Exhibits138: Grifols SA – Overview
Exhibits139: Grifols SA – Business segments
Exhibits140: Grifols SA – Key offerings
Exhibits141: Grifols SA – Segment focus
Exhibits142: LG Corp. – Overview
Exhibits143: LG Corp. – Business segments
Exhibits144: LG Corp. – Key offerings
Exhibits145: LG Corp. – Segment focus
Exhibits146: Meiji Holdings Co. Ltd. – Overview
Exhibits147: Meiji Holdings Co. Ltd. – Business segments
Exhibits148: Meiji Holdings Co. Ltd. – Key news
Exhibits149: Meiji Holdings Co. Ltd. – Key offerings
Exhibits150: Meiji Holdings Co. Ltd. – Segment focus
Exhibits151: Merck and Co. Inc. – Overview
Exhibits152: Merck and Co. Inc. – Business segments
Exhibits153: Merck and Co. Inc. – Key news
Exhibits154: Merck and Co. Inc. – Key offerings
Exhibits155: Merck and Co. Inc. – Segment focus
Exhibits156: Mitsubishi Chemical Holdings Corp. – Overview
Exhibits157: Mitsubishi Chemical Holdings Corp. – Business segments
Exhibits158: Mitsubishi Chemical Holdings Corp. – Key offerings
Exhibits159: Mitsubishi Chemical Holdings Corp. – Segment focus
Exhibits160: Pfizer Inc. – Overview
Exhibits161: Pfizer Inc. – Product / Service
Exhibits162: Pfizer Inc. – Key news
Exhibits163: Pfizer Inc. – Key offerings
Exhibits164: Sanofi SA – Overview
Exhibits165: Sanofi SA – Business segments
Exhibits166: Sanofi SA – Key news
Exhibits167: Sanofi SA – Key offerings
Exhibits168: Sanofi SA – Segment focus
Exhibits169: Serum Institute of India Pvt. Ltd. – Overview
Exhibits170: Serum Institute of India Pvt. Ltd. – Product / Service
Exhibits171: Serum Institute of India Pvt. Ltd. – Key offerings
Exhibits172: Inclusions checklist
Exhibits173: Exclusions checklist
Exhibits174: Currency conversion rates for US$
Exhibits175: Research methodology
Exhibits176: Validation techniques employed for market sizing
Exhibits177: Information sources
Exhibits178: List of abbreviations
|
| ※본 조사보고서 [세계의 인간용 혼합 백신 시장 (2023년~2027년)] (코드 : IRTNTR44620-23) 판매에 관한 면책사항을 반드시 확인하세요. |
| ※본 조사보고서 [세계의 인간용 혼합 백신 시장 (2023년~2027년)] 에 대해서 E메일 문의는 여기를 클릭하세요. |
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요! 세계의 인간용 혼합 백신 시장 (2023년~2027년)
